Bibliography

Found 1068 results

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Geraci A, DiRocco A, Liu M, Werner P, Tagliati M, Godbold J, Simpson DM, Morgello S. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid. Neurology [Internet]. 2000 ;55(3):440-442. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10932285

Fields JA, Spencer B, Swinton M, Qvale EMartine, Marquine MJ, Alexeeva A, Gough S, Soontornniyomkij B, Valera E, Masliah E, et al. Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J Neurochem. 2018 .

Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24292993

Grigorian A, Hurford R, Chao Y, Patrick C, Langford TD. Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir. BMC Neuroscience [Internet]. 2008 ;9:27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18302767

Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D. Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression. J Acquir Immune Defic Syndr. 2015 ;69(1):18-28.

Fischer-Smith T, Croul S, Haxhistasa O, Bonwetsch R, Adeniyi A, Rybicka K, Morgello S, Khalili K, Rappaport J. Altered monocyte/macrophage trafficking in CNS and visceral tissues in HIV encephalopathy. In: Journal of NeuroVirology. Vol. 10. Journal of NeuroVirology. ; 2004. p. 15.

Jensen BK, Monnerie H, Mannell MV, Gannon PJ, Espinoza CAkay, Erickson MA, Bruce-Keller AJ, Gelman B, Briand LA, R. Pierce C, et al. Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders. [Internet]. 2015 ;74(11):1093 - 1118. Available from: http://dx.doi.org/10.1097/NEN.0000000000000255

Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen LA, Masliah E. Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. Journal of Neuropathology and Experimental Neurology [Internet]. 2004 ;63(10):1038-47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15535131

Lucas CH, Calvez M, Babu R, Brown A. Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neuroscience Letters [Internet]. 2014 ;558:97-102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24215932

Lucas C-H, Calvez M, Babu R, Brown A. Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neurosci Lett. 2014 ;558:97-102.

Shapshak P, Rodriguez HE, Kayathri R, Levine AJ, Chiappelli F, Minagar A. Alzheimer's disease and HIV associated dementia related genes: I. location and function. Bioinformation [Internet]. 2008 ;2:348-57. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=18685724

Morgello S, Jacobs M, Murray J, Byrd D, Neibart E, Mintz L, Meloni G, Chon C, Crary J. Alzheimer's disease neuropathology may not predict functional impairment in HIV: a report of two individuals. J Neurovirol. 2018 ;24(5):629-637.

Sundermann EE, Campbell LM, Villers O, Bondi MW, Gouaux B, Salmon DP, Galasko D, Soontornniyomkij V, Ellis RJ, Moore DJ. Alzheimer's Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer's Disease Trajectory and Relationships with Cognitive Function. Viruses. 2023 ;15(6).

Ellis RJ, Pal S, Achim CL, Sundermann E, Moore DJ, Soontornniyomkij V, Feldman H. Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach. Res Sq. 2023 .

Everall I, Trillo-Pazos G, Bell C, Mallory ME, Sanders VJ, Masliah E. Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection. Journal of Neuropathology and Experimental Neurology [Internet]. 2001 ;60(3):293-301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11245213

Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford FT, Venketaraman V. Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process. BBA Clinical. 2016 ;6:38-44.

Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford FT, Venketaraman V. Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process. BBA Clin. 2016 ;6:38-44.

Chismar JD, Mondala T, Fox HS, Roberts ES, Langford D, Masliah E, Salomon DR, Head SR. Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. BioTechniques [Internet]. 2002 ;33(3):516-518, 520, 522 passim. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12238761

Shapshak P, Duncan R, Torres-Munoz JE, Duran EM, Minagar A, Petito C. Analytic approaches to differential gene expression in AIDS versus control brains. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2004 ;9:2935-46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15353327

Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, et al. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. J Infect Dis. 2016 ;213(7):1065-73.

Fields JA, Metcalf J, Overk C, Adame A, Spencer B, Wrasidlo W, Florio J, Rockenstein E, He JJ, Masliah E. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol. 2017 ;23(2):290-303.

Devanathan AS, Pirone JR, Akkina R, Remling-Mulder L, Luciw P, Adamson L, J Garcia V, Kovarova M, White NR, Schauer AP, et al. Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs. Antimicrob Agents Chemother. 2019 ;64(1).

Devanathan AS, Fallon JK, White NR, Schauer AP, Van Horne B, Blake K, Sykes C, Kovarova M, Adamson L, Remling-Mulder L, et al. Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans. Antimicrob Agents Chemother. 2020 ;64(10).

Bryant AK, Ellis RJ, Umlauf A, Gouaux B, Soontornniyomkij V, Letendre SL, Achim CL, Masliah E, Grant I, Moore DJ. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 ;29(3):323-30.

Tarassishin L, Bauman A, Suh H-S, Lee SC. Anti-Viral and Anti-Inflammatory Mechanisms of the Innate Immune Transcription Factor Interferon Regulatory Factor 3: Relevance to Human CNS Diseases. J Neuroimmune Pharmacol [Internet]. 2010 . Available from: http://www.ncbi.nlm.nih.gov/pubmed/22684309

Pages